Clin Lab Expo & Conference / DIAGNOSTICA (in- vitro (Diagnostics Pavilion)

Clin Lab/ IVD pavilion and conference

Clin Lab India is an Exhibition & Conference platform (7th edition) that focuses on Laboratory Medicine, Point of Care Testing, Molecular Medical Diagnostics and Clinical Chemistry. It highlights recent developments and market trends in the IVD and allied areas. The Conference brings together the top leaders in the Medical Laboratory industry. It is designed to create a conducive environment for maximum interaction and meeting opportunities for the industry peers, enabling manufacturers, dealers and distributors to promote their brands, meet potential customers and entertain existing clients. It is the premier platform for Laboratory Medicine, Point of Care Testing, and Molecular Diagnostics. This edition focuses on a transformative goal: achieving Atmanirbhar Bharat by transitioning from late-stage assembly to a fully indigenous IVD production ecosystem.

Building Diagnostic Resilience: Strengthening India’s Supply Chain

Upstream Independence: Localizing Critical Inputs

Panel: “From Molecule to Machine: Building India’s Core IVD Input Ecosystem”
Topics: enzymes, antibodies, plastics, microfluidics, sensors, CDMOs, testing labs, global case studies.

Downstream Efficiency: Smart Distribution, Traceability & Access

Panel: From Factory to Field: Reinventing India’s diagnostic Delivery Chain”
Topics: AI forecasting, Blockchain, Cold-chain, Warehousing, Tier-2/3 access, TAT reduction.

Ecosystem Governance: Policies, Partnerships & Quality Systems

Panel: “Policies that Power Diagnostics: Catalyzing India’s Supply Chain Future”
Topics: PLI 2.0, CDSCO Modernization, clusters, academia partnerships, national supply chain grid.

IVD & Biotech Companies: Leadership and technical teams.
Ancillary Stakeholders: Manufacturers of raw materials, components, and electronics.
Healthcare Providers: Management from Hospitals, Labs, Blood Banks, and CROs.
Academia & Innovators: Startups and researchers in the MedTech space.
Government: Representatives and policymakers.
Other stakeholders

Date: 30th January 2026 (Friday)
Time: 10:00 AM – 5:00 PM
Venue: Bharat Mandapam (Pragati Maidan), New Delhi

Theme: Building Diagnostic Resilience: Strengthening India’s Supply Chain

Tagline: From Raw Material to Results – Powering India’s Self-Reliant IVD Ecosystem

To reduce import dependency, we are fostering a cross-disciplinary alliance. We invite Ancillary Sectors —including Biotech/Chemical Sciences (Enzymes/Antibodies), Precision Engineering (Sensors/Microfluidics), and Technology (AI/Blockchain/Cold-chain)—to integrate into the IVD supply chain and strengthen India's manufacturing backbone.

Panel 1: Upstream Independence - Topic: Localizing critical inputs (enzymes, antibodies, sensors, and CDMOs) to build the core IVD ecosystem.

Panel 2: Downstream Efficiency - Topic: Reinventing delivery through AI forecasting, blockchain, and cold-chain innovations to improve access in Tier-2/3 cities.

Panel 3: Ecosystem Governance - Topic: Catalyzing the future via PLI 2.0, CDSCO modernization, and industry-academia partnerships.

Mr. Jatin Mahajan
MD - J Mitra & Co
Conference Chair - Clin Lab India Expo & Conference 2026
Medical Fair India

Ms. Rama Venugopal
MD - J Mitra & Co
Vice Chairperson - Clin Lab India Expo & Conference 2026
Medical Fair India

Attending Clin Lab India 2026 provides a unique strategic advantage by placing participants at the center of India’s evolving IVD manufacturing landscape.

For manufacturers and ancillary partners, the conference offers a high-level matchmaking environment to discover local sourcing opportunities, reduce import dependency, and diversify revenue streams through new cross-sector collaborations.

Healthcare providers and lab management will gain direct insights into cutting-edge technologies that optimize turnaround times and operational efficiency, while startups and policymakers can engage in vital dialogues regarding PLI schemes, regulatory modernization, and the infrastructure needed to scale "Make in India" innovations.

By bridging the gap between raw material suppliers and end-market results, the event empowers every stakeholder to mitigate supply chain risks, align with national self-reliance goals, and collectively transform India into a global hub for resilient and high-quality diagnostic excellence.

Source Local: Manufacturers can identify domestic suppliers to mitigate global risks.
Market Growth: Ancillary providers can tap into the rapidly expanding Indian IVD market.
Network: Engage in high-level matchmaking with industry leaders and policymakers.

Join us at Bharat Mandapam to bridge the gap between "Raw Material" and "Results" and power the future of Indian Diagnostics.